Obed Boadi Amissah
Obed Boadi Amissah publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Advanced biosensing and bioanalysis techniques.
- World rank
- #2,421,902 of 7,710,434 ranked researchers
- Rank in China
- #378,040 of 978,568
- Works
- 22
- Citations
- 245
- Citations per work
- 11.1
What does Obed Boadi Amissah research?
Obed Boadi Amissah's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else837.4%
- Life Sciences729.7%
- Health Sciences628.2%
- Medicine628.2%
- Physical Sciences14.7%
- Engineering14.7%
- 1Molecular Biology23% of their works
- 2Oncology17% of their works
- 3Immunology6% of their works
- 4Infectious Diseases6% of their works
- 5Surgery5% of their works
- 6Biomedical Engineering5% of their works
Research topics
- CAR-T cell therapy research
- Monoclonal and Polyclonal Antibodies Research
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
- Viral Infectious Diseases and Gene Expression in Insects
- FOXO transcription factor regulation
- Immunotherapy and Immune Responses
- Diverse Scientific Research Studies
Which keywords describe Obed Boadi Amissah's research?
The keywords of their largest research topics: Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Nanoparticles, Fc Receptors, Therapeutic Antibodies and cell cycle regulation.
- Self-Assembly
- RNA-Guided
- Mammalian Cells
- Genome Engineering
- Dendritic Cells
- COVID-19
- Fc Receptors
- Glycosylation
- CAR T Cells
- Cancer Immunotherapy
- Chimeric Antigen Receptor
- Nanoparticles
- Therapeutic Antibodies
- DNA nanotechnology
- FoxO Transcription Factors
- Immunity
- Pandemic
- Recombinant Protein
- cell cycle regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Cancer Immunotherapy82 topics
- CAR T Cells61 topic
- Chimeric Antigen Receptor61 topic
- Glycosylation52 topics
- Nanoparticles42 topics
- Fc Receptors31 topic
- Therapeutic Antibodies31 topic
- COVID-1921 topic
- DNA nanotechnology21 topic
- Dendritic Cells21 topic
- FoxO Transcription Factors21 topic
- Genome Engineering21 topic
- Immunity21 topic
- Mammalian Cells21 topic
- Pandemic21 topic
- RNA-Guided21 topic
- Recombinant Protein21 topic
- Self-Assembly21 topic
- cell cycle regulation21 topic
Where does Obed Boadi Amissah work?
Obed Boadi Amissah's main affiliation in the publication record is Guangzhou Institutes of Biomedicine and Health, China.
How many publications and citations does Obed Boadi Amissah have?
OpenAlex counts 22 works and 245 citations for Obed Boadi Amissah, an h-index of 8, ranking #2,421,902 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Obed Boadi Amissah. Posts are plain text and can be reported.